• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄牙类风湿关节炎患者生物治疗使用建议——2016年更新版

Portuguese Recommendations for the use of biological therapies in patients with rheumatoid arthritis- 2016 update.

作者信息

Duarte Catia, Sousa-Neves Joana, Águeda Ana, Ribeiro Pedro, Daniel Alexandra, Eugénio Gisela, Serra Sofia, Araújo Filipe, Barcelos Anabela, Filipe Barcelos, Bernardes Miguel, Canhão Helena, Cerqueira Marcos, Capela Susana, Cordeiro Ana, Costa Flavio, Costa Lucia, Cruz Margarida, Cunha Miranda Luis, Duarte Catarina, Falcão Sandra, Faria Daniela, Figueira Ricardo, Freitas João Pedro, Gonçalves Maria João, Madruga Dias João, Melo Gomes José, Mourão Ana Filipa, Neto Adriano, Oliveira Ramos Filipa, Pimenta Sofia, Pinto Patricia, Polido-Pereira Joaquim, Ponte Cristina, Ramos João, Rodrigues Ana, Santos Helena, Santos Maria José, Sepriano Alexandre, Silva Candida, Tavares Costa José, Teixeira Filipa, Teixeira Vitor, Valente Paula, Vieira-Sousa Elsa, Barros Rita, Abreu Pedro, Fonseca João Eurico

机构信息

Centro Hospitalar Universitário de Coimbra.

Unidade Local de Saúde Alto Minho.

出版信息

Acta Reumatol Port. 2017 Jun 1;42(2)(Apr-Jun):112-126.

PMID:28535544
Abstract

OBJECTIVE

To update the recommendations for the treatment of Rheumatoid Arthritis (RA) with biological therapies, endorsed by the Portuguese Society of Rheumatology (SPR).

METHODS

These treatment recommendations were formulated by Portuguese rheumatologists based on literature evidence and consensus opinion. At a national meeting the 10 recommendations were discussed and updated. The document resulting from this meeting circulated to all Portuguese rheumatologists, who anonymously voted online on the level of agreement with the recommendations.

RESULTS

These recommendations cover general aspects as shared decision, prospective registry in Reuma.pt, assessment of activity and RA impact and treatment objective. Consensus was also achieved regarding specific aspects as initiation of biologic therapy, assessment of response, switching and definition of persistent remission.

CONCLUSION

These recommendations may be used for guidance of treatment with biological therapies in patients with RA. As more evidence becomes available and more therapies are licensed, these recommendations will be updated.

摘要

目的

更新由葡萄牙风湿病学会(SPR)认可的类风湿关节炎(RA)生物治疗的推荐意见。

方法

这些治疗推荐意见由葡萄牙风湿病学家根据文献证据和共识意见制定。在一次全国性会议上对10条推荐意见进行了讨论和更新。此次会议形成的文件分发给了所有葡萄牙风湿病学家,他们在网上对这些推荐意见的认同程度进行了匿名投票。

结果

这些推荐意见涵盖了共同决策、在Reuma.pt进行前瞻性登记、活动度和RA影响评估以及治疗目标等一般方面。在生物治疗的起始、反应评估、换药以及持续缓解的定义等具体方面也达成了共识。

结论

这些推荐意见可用于指导RA患者的生物治疗。随着更多证据的出现以及更多疗法获得许可,这些推荐意见将得到更新。

相似文献

1
Portuguese Recommendations for the use of biological therapies in patients with rheumatoid arthritis- 2016 update.葡萄牙类风湿关节炎患者生物治疗使用建议——2016年更新版
Acta Reumatol Port. 2017 Jun 1;42(2)(Apr-Jun):112-126.
2
Portuguese recommendations for the use of biological and targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis - 2020 update.葡萄牙类风湿关节炎患者生物制剂和靶向合成改善病情抗风湿药物使用建议-2020 更新版。
ARP Rheumatol. 2022 Jan-Mar;1(1):63-82.
3
Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis--December 2011 update.葡萄牙关于轴性脊柱关节炎患者生物疗法使用的建议——2011年12月更新版
Acta Reumatol Port. 2012 Jan-Mar;37(1):40-7.
4
PORTUGUESE RECOMMENDATIONS FOR THE USE OF BIOLOGICAL THERAPIES IN PATIENTS WITH PSORIATIC ARTHRITIS--2015 UPDATE.葡萄牙关于银屑病关节炎患者生物治疗使用的建议——2015年更新版
Acta Reumatol Port. 2015 Jul-Sep;40(3):275-90.
5
2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis.2011年葡萄牙关于银屑病关节炎患者生物疗法使用的建议。
Acta Reumatol Port. 2012 Jan-Mar;37(1):26-39.
6
Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis - 2016 update.
Acta Reumatol Port. 2017 Jul-Sep;42(3):209-218.
7
Portuguese recommendations for the use of methotrexate in rheumatic diseases - 2016 update.葡萄牙关于甲氨蝶呤在风湿性疾病中应用的建议——2016年更新版
Acta Reumatol Port. 2017 Apr-Jun;42(2):127-140.
8
Portuguese recommendations for the use of biological therapies in children and adolescents with juvenile idiopathic arthritis--December 2011 update.
Acta Reumatol Port. 2012 Jan-Mar;37(1):48-68.
9
2016 update of the Portuguese recommendations for the use of biological therapies in children and adolescents with Juvenile Idiopathic Arthritis.葡萄牙关于青少年特发性关节炎儿童及青少年生物疗法使用建议的2016年更新版。
Acta Reumatol Port. 2016 Jul-Sep;41(3):194-212.
10
Portuguese recommendations for the prevention, diagnosis and management of primary osteoporosis - 2018 update.葡萄牙原发性骨质疏松症预防、诊断与管理建议——2018年更新版
Acta Reumatol Port. 2018 Jan-Mar;43(1):10-31.

引用本文的文献

1
Evaluating the benefits of TNF-alfa inhibitor biosimilar competition on off-patent and on-patent drug markets: A Southern European analysis.评估肿瘤坏死因子-α抑制剂生物类似药竞争对专利过期药物市场和专利药物市场的益处:一项南欧分析。
Front Pharmacol. 2022 Dec 16;13:1031910. doi: 10.3389/fphar.2022.1031910. eCollection 2022.
2
Translating IL-6 biology into effective treatments.将 IL-6 生物学转化为有效治疗方法。
Nat Rev Rheumatol. 2020 Jun;16(6):335-345. doi: 10.1038/s41584-020-0419-z. Epub 2020 Apr 23.
3
Switching of biological therapies in Brazilian patients with rheumatoid arthritis.
巴西类风湿关节炎患者生物疗法的转换
Future Sci OA. 2018 Dec 4;5(1):FSO355. doi: 10.4155/fsoa-2018-0025. eCollection 2019 Jan.